☆ 4.7 Article

Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement

BIOMEDICINES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Neurosciences

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis

Matteo Lucchini et al.

Summary: This study assessed the concentration of several biomarkers in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients and investigated their diagnostic and prognostic significance. The results showed that higher CSF levels of CHI3L1 and CXCL13 were associated with a higher risk of relapse, MRI activity, and overall disease activity in MS patients. These findings suggest that CSF CHI3L1 and CXCL13 levels can serve as good prognostic biomarkers in MS patients and aid in treatment decisions. The study also found differences in CSF BAFF and APRIL levels between different phases of MS, indicating the modulation of B-cells pathways vary in different disease stages.

MOLECULAR NEUROBIOLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus

Maria Boge Lauvsnes et al.

Summary: The study found that increased plasma NfL concentrations in SLE patients were associated with abnormal neurological, cognitive, and neuroimaging findings, but were also influenced by factors such as damage accrual, creatinine, and Q-albumin, obscuring the interpretation of CNS involvement. Ultimately, NfL in CSF appears to be a better marker of neuronal injury than plasma NfL in SLE patients.

JOURNAL OF NEUROLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis

Ruba S. Saadeh et al.

Summary: The study aims to determine and validate a cerebrospinal fluid (CSF) k (KCSF) value comparable to the detection of cerebrospinal fluid-specific oligoclonal bands (OCB) for diagnosing multiple sclerosis (MS). The results show that a KCSF value of 0.1 mg/dL can be used as a valid alternative to OCB testing, providing a standardized quantitative measure with similar sensitivity and specificity, and reducing human error and cost.

MAYO CLINIC PROCEEDINGS (2022)

添加到收藏夹

Article Clinical Neurology

The frequency and characteristics of multiple sclerosis misdiagnosis in Latin America: A referral center study in Buenos Aires, Argentina

Maria Gaitan et al.

Summary: This study in an MS referral center in Argentina found that 16% of patients with established MS were subsequently found to have been misdiagnosed. Women were at higher risk for misdiagnosis, and expert application of the McDonald criteria may prevent misdiagnosis and its associated morbidity and healthcare system cost.

MULTIPLE SCLEROSIS JOURNAL (2022)

添加到收藏夹

Article Immunology

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities

Michael Levraut et al.

Summary: This study aimed to analyze the concentrations of several cytokines in cerebrospinal fluid (CSF) and correlate them with the final diagnosis in patients with brain white matter hyperintensities (WMH). The results showed that CSF KFLC index and KFLC fraction were helpful in diagnosing multiple sclerosis and related disorders, while elevated CSF CD25 and IL-6 concentrations could rule out multiple sclerosis.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the Attikon Lupus Cohort

Dionysis Nikolopoulos et al.

Summary: In a large SLE cohort, CNS demyelinating syndromes were characterized as neuropsychiatric SLE (NPSLE) or SLE-MS overlap. Patients with SLE-MS overlap had a higher likelihood of neurologic relapses, while those with SLE-demyelination were less likely to have neurological deficits at the last follow-up visit.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Review Medical Laboratory Technology

An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond

Ruba S. Saadeh et al.

Summary: Multiple sclerosis (MS) is an immune-mediated central nervous system inflammatory demyelinating disease. Laboratory tests play an important role in the diagnosis of MS. Biomarkers discovered in the past two decades have been incorporated into clinical practice for the diagnosis of MS mimics. This review summarizes the importance of test selection, assay methodology, optimal sample for testing, and diagnostic utility of these biomarkers. Other laboratory testing methods that can aid in the differentiation between MS and biomarker-defined CNS demyelinating diseases are described. The role of biomarkers of disease activity and prognosis is also discussed, along with future perspectives and the potential for discovering additional biomarkers.

CLINICAL CHEMISTRY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

=Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

Dimitris K. K. Karathanasis et al.

Summary: Objective: This study aimed to explore whether distinct clinical, laboratory, and imaging characteristics along with quantitation of peripheral blood type I interferon (IFN) activity could aid in differentiating between multiple sclerosis (MS) and systemic autoimmune diseases (SADs). The results showed that patients with CNS autoimmune disorders have different clinical, imaging, and laboratory characteristics compared to those with MS spectrum disorders. In addition, patients fulfilling SAD criteria showed significantly higher peripheral blood type I IFN activity, indicating it as a potential therapeutic target.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Clinical Neurology

An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis

Marwa Kaisey et al.

Summary: This review summarizes recent studies on fluid biomarkers for multiple sclerosis (MS), with a focus on blood biomarkers. The research in this field is still in its early stages and accurate and easily obtainable biomarkers for MS have not yet been identified and validated. Continuing efforts to define laboratory diagnostic biomarkers are likely to play an increasingly important role in defining MS at the earliest stages, leading to better long-term clinical outcomes.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2022)

添加到收藏夹

Review Chemistry, Analytical

Multiple Sclerosis Diagnosis Using Machine Learning and Deep Learning: Challenges and Opportunities

Nida Aslam et al.

Summary: This article reviews the application of machine learning in diagnosing Multiple Sclerosis (MS). Researchers have developed various models using different types of data such as MRI and clinical data. SVM, RF, and CNN are identified as the most successful approaches. The article discusses the challenges in MS diagnosis, including differentiating the disease from others with similar symptoms, data confidentiality, interpretability, and the difficulty of collecting large reliable datasets. Moreover, opportunities such as secure platforms, better AI solutions, and combining different data types are discussed to improve the automated diagnosis of MS.

SENSORS (2022)

添加到收藏夹

Article Infectious Diseases

Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6

Trine Andreasen Leth et al.

Summary: This study evaluated the diagnostic performance of CXCL13 and IL-6 in differentiating between definite and possible LNB, as well as between LNB and other neuroinfections. The results suggest that CXCL13 is a valuable supplement for diagnosing LNB, and the combination of CXCL13 and IL-6 can help differentiate between cases of LNB and other CNS infections. Additionally, IL-6 may be useful for differential diagnosis in patients with possible LNB.

TICKS AND TICK-BORNE DISEASES (2022)

添加到收藏夹

Article Clinical Neurology

Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus

Kristoffer A. Zervides et al.

Summary: This cross-sectional study found that plasma and cerebrospinal fluid (CSF) concentrations of neurofilament light (NfL) were elevated in patients with systemic lupus erythematosus (SLE), indicating neuronal damage.

BMC NEUROLOGY (2022)

添加到收藏夹

Article Rheumatology

Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort

Dionysis Nikolopoulos et al.

Summary: Patients with CNS demyelinating syndromes not fulfilling the criteria for MS were prospectively evaluated for features of SLE. At follow-up, a significant number of patients evolved into MS, while others had SLE or exhibited systemic autoimmunity without meeting classification criteria for SLE. These patients were less likely to have elevated IgG index and positive oligoclonal bands.

RHEUMATOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia

Luciana Midaglia et al.

Summary: A low frequency of MS misdiagnosis was found in the clinical setting, with multifocal non-specific white matter lesions, comorbidities, and personal history of autoimmunity potentially contributing to misdiagnosis.

MULTIPLE SCLEROSIS JOURNAL (2021)

添加到收藏夹

Article Neurosciences

Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis

Keld-Erik Byg et al.

Summary: NFL levels in cerebrospinal fluid and plasma are significantly higher in neurosarcoidosis patients compared to extra-neurologic patients and healthy controls, and the levels correlate to the extent of inflammation on MRI.

BRAIN SCIENCES (2021)

添加到收藏夹

Review Cell Biology

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis

Franz Felix Konen et al.

Summary: Free light chains (FLC), particularly the kappa isoform (KFLC), show high diagnostic sensitivity and specificity in detecting intrathecal inflammation in central nervous system diseases. The measurement of KFLC is fully automated, stable against most influencing factors, and represents a promising diagnostic approach for neuroinflammatory diseases. Further multicenter studies are needed to establish the diagnostic sensitivity and specificity of KFLC, using standardized cut-off values and non-linear formulas.

CELLS (2021)

添加到收藏夹

Editorial Material Clinical Neurology

Misdiagnosis of multiple sclerosis: Time for action

Wallace J. Brownlee et al.

MULTIPLE SCLEROSIS JOURNAL (2021)

添加到收藏夹

Article Clinical Neurology

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

Mike P. Wattjes et al.

Summary: The 2021 revision of guidelines on MRI use for multiple sclerosis patients integrates recommendations from various organizations to improve the application of MRI for diagnosis, prognosis, and monitoring of individuals with multiple sclerosis. It suggests changes in MRI acquisition protocols, cautious use of gadolinium-based contrast agents, and extends recommendations to the use of MRI in children, during pregnancy, and in the post-partum period for patients with multiple sclerosis.

LANCET NEUROLOGY (2021)

添加到收藏夹

Article Immunology

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

Carmen Picon et al.

Summary: Patients with multiple sclerosis (MS) undergo an early immunosenescence process with age, impacting treatment response and infection risks. Lipid-specific oligoclonal IgM bands (LS-OCMB) in MS patients may modify the immunological profile influenced by age. Additionally, age leads to changes in CSF levels of various molecules and cellular subsets, affecting disability in MS patients.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Neurofilament light is a biomarker of brain involvement in lupus and primary Sjogren's syndrome

Anne B. Tjensvoll et al.

Summary: The study found that increased levels of neurofilament light (NfL) in cerebrospinal fluid are associated with cerebral involvement in patients with systemic lupus erythematosus (SLE) and primary Sjogren's syndrome (pSS), strongly correlated with the presence of anti-NR2 antibodies, and related to cognitive impairment in multiple domains.

JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

C. E. Leurs et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

添加到收藏夹

Review Clinical Neurology

Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases

Paula Wildner et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases

Pavlina Kusnierova et al.

PLOS ONE (2020)

添加到收藏夹

Article Cell Biology

Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis

Ekaterina Martynova et al.

MEDIATORS OF INFLAMMATION (2020)

添加到收藏夹

Article Immunology

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

M. N. Olesen et al.

JOURNAL OF NEUROINFLAMMATION (2019)

添加到收藏夹

Article Clinical Neurology

The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and-10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study

T. Chazal et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

添加到收藏夹

Article Clinical Neurology

Better explanations in multiple sclerosis diagnostic workup A 3-year longitudinal study

Massimiliano Calabrese et al.

NEUROLOGY (2019)

添加到收藏夹

Article Clinical Neurology

Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers

Marwa Kaisey et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)

添加到收藏夹

Review Clinical Neurology

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Claire Bridel et al.

JAMA NEUROLOGY (2019)

添加到收藏夹

Review Neurosciences

Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients

Zhile Bai et al.

FRONTIERS IN NEUROSCIENCE (2019)

添加到收藏夹

Review Clinical Neurology

Misdiagnosis of multiple sclerosis Impact of the 2017 McDonald criteria on clinical practice

Andrew J. Solomon et al.

NEUROLOGY (2019)

添加到收藏夹

Review Immunology

Molecular biomarkers in multiple sclerosis

Tjalf Ziemssen et al.

JOURNAL OF NEUROINFLAMMATION (2019)

添加到收藏夹

Editorial Material Clinical Neurology

Use (and misuse) of the McDonald criteria to diagnose multiple sclerosis

W. J. Brownlee

EUROPEAN JOURNAL OF NEUROLOGY (2018)

添加到收藏夹

Article Clinical Neurology

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

Georgina Arrambide et al.

BRAIN (2018)

添加到收藏夹

Review Multidisciplinary Sciences

Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis

Elmira Agah et al.

PLOS ONE (2018)

添加到收藏夹

Review Clinical Neurology

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature

S. Jarius et al.

JOURNAL OF NEUROLOGY (2017)

添加到收藏夹

Article Oncology

Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma

Felicitas Strehlow et al.

JOURNAL OF NEURO-ONCOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study

Andrew J. Solomon et al.

NEUROLOGY (2016)

添加到收藏夹

Article Immunology

Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases

Kunihiro Ichinose et al.

CLINICAL IMMUNOLOGY (2015)

添加到收藏夹

Article Clinical Neurology

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

M. Alba Mane Martinez et al.

MULTIPLE SCLEROSIS JOURNAL (2015)

添加到收藏夹

Article Clinical Neurology

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

G. Hinsinger et al.

MULTIPLE SCLEROSIS JOURNAL (2015)

添加到收藏夹

Article Clinical Neurology

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

M. Alba Mane Martinez et al.

MULTIPLE SCLEROSIS JOURNAL (2015)

添加到收藏夹

Article Clinical Neurology

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

G. Hinsinger et al.

MULTIPLE SCLEROSIS JOURNAL (2015)

添加到收藏夹

Article Clinical Neurology

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude

Ruth Dobson et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

添加到收藏夹

Article Clinical Neurology

CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions

Enrique Alvarez et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

添加到收藏夹

Article Clinical Neurology

Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis

Jorge Correale et al.

MULTIPLE SCLEROSIS JOURNAL (2011)

添加到收藏夹

Article Clinical Neurology

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

F. Sellebjerg et al.

NEUROLOGY (2009)

添加到收藏夹

Article Clinical Neurology

Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis

Manjit Braitch et al.

ARCHIVES OF NEUROLOGY (2008)

添加到收藏夹

Article Clinical Neurology

Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis

Soheli A. Chowdhury et al.

ARCHIVES OF NEUROLOGY (2008)

添加到收藏夹

Article Clinical Neurology

Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseases

I Mayringer et al.

EUROPEAN JOURNAL OF NEUROLOGY (2005)

添加到收藏夹

Review Clinical Neurology

Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis -: A consensus statement

MS Freedman et al.

ARCHIVES OF NEUROLOGY (2005)

添加到收藏夹

Article Clinical Neurology

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

N Norgren et al.

NEUROLOGY (2004)

添加到收藏夹

Article Clinical Neurology

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

C Malmeström et al.

NEUROLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.